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Quinoa is a pseudo-grain consumed as a dietary staple in South America. In recent 
years, consumer demand for quinoa in the developed world has grown steadily. Its 
perceived health benefits have been cited as a driving force behind this trend, but 
there are very few human studies investigating the impact of quinoa consumption. 
The aim of this review was to identify physiological effects of quinoa consumption 
with potential for human health. A critical evaluation of animal model studies was 
conducted. The quality of identified studies was assessed using a methodological 
quality assessment tool and summative conclusions were drawn to guide the direction 
of future human research. The majority of studies were of fair quality. Purported 
physiological effects of quinoa consumption included decreased weight gain, 
improved lipid profile and improved capacity to respond to oxidative stress. These 
physiological effects were attributed to the presence of saponins, protein and 20-
 2
hydroxyecdysone in the quinoa seed. The implications of these findings are that 
human studies should investigate the impact of quinoa consumption on weight gain 
and lipid levels. The role of quinoa as an antioxidant is still unclear and requires 
further elucidation in animal models.  
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Across the globe, cereals form an integral part of the human diet, with an estimated 
35% of daily dietary energy derived from this source [1]. Specifically, cereals 
encompass grains, such as wheat and barley as well as pseudo-grains such as quinoa 
and buckwheat [2]. Inclusion of the whole grain form of cereals in the diet is 
associated with health benefits such as a reduction in the risk of developing 
cardiovascular disease and diabetes [2]. These properties have contributed to the 
establishment of dietary guidelines that encourage the regular consumption of whole 
grains in the diet [3,4]. 
As a consequence of the health benefits that whole grains offer, research efforts have 
begun to concentrate on specific grains and the role they could play in human 
nutrition. Quinoa is an example of a pseudo-grain that has been grown in the Andes 
and used for human consumption and livestock feed for thousands of years [5]. The 
leading producers of quinoa are Peru and Bolivia [6], however there is emerging 
global interest to produce quinoa as an alternative food crop [5]. Desirable agronomic 
properties [7] in conjunction with higher prices induced by increased demand [8] have 
been the drivers of this emerging interest.  
As global awareness continues to grow, research efforts exploring the possible health 
benefits associated with quinoa consumption become more valuable. Unique health 
imparting properties increase the marketability of a food and are of interest to 
manufacturers to pursue. As an example, quinoa protein, unlike most other grains, is 
not limited by the amino acid lysine [9-11] creating a point of differentiation and 
potential health advantage. In vitro experiments have shown that the digestibility of 
starch from quinoa is similar to pasta and lower than white bread [12] while the 
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antioxidant potential is similar to wheat and superior to other so-called ancient grains 
such as amaranth [13].  
Reviews synthesising the literature surrounding quinoa have focussed on the nutrient 
composition [14,7], as well as the functional potential of quinoa in the human diet [5]. 
Recently, it has been suggested that conducting systematic reviews of preclinical 
studies, such as animal studies, is a valuable tool for establishing the likelihood of 
mechanistic understanding being translated into human research applications [15]. In 
particular, evaluating the validity of the methods underpinning these studies and the 
results that are generated can determine hypotheses for future human studies. This is 
relevant to quinoa as it is becoming an increasingly popular food, but its human health 
benefits are relatively poorly researched. The primary aim of this review was to 
identify physiological effects from quinoa consumption, which have potential for 
human health benefits. The implications for research involving humans are discussed. 
Method 
A systematic review of the scientific literature was conducted according to published 
standards. Since animal studies were the focus, the quality appraisal approach defined 
by Downs and Black [16] and adjusted for use among animal studies by Ainge et al. 
[17] was applied. 
Inclusion and exclusion criteria 
The eligibility criteria were determined prior to the commencement of the search so as 
to minimise any bias in inclusion and exclusion of studies. All animal studies that 
investigated the impact of quinoa consumption on physiological outcomes were 
considered for inclusion. Included papers were limited to original research published 
since 1975 in peer reviewed journals and published in the English language. Studies 
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were excluded if they did not include quinoa as part of an experimental diet. 
Previously conducted reviews were also excluded from this systematic review. 
Search terms and strategy 
“Quinoa”, “animal”, “health” and “feeding” formed the search terms. Combinations 
of these terms were joined with the Boolean operator ‘AND’ to identify relevant 
articles. The search encompassed the time period from 1975 onwards (40 year period) 
and involved seeking relevant articles from the following electronic databases: 
Agricola, Cambridge Journals Online, Cochrane Library, CINAHL, MEDLINE, 
PubMed, SAGE Journals Online, ScienceDirect, Scopus, SPORTDiscus, Springer 
Link, Web of Science and Wiley Online. The same set of search terms were used in 
each database during the search phase, performed in February 2015.  
Initially, the title of the article was examined for inclusion. Articles, which appeared 
to be of relevance, were further reviewed through their abstract to determine if they 
met the eligibility criteria. The full text of articles whose abstract met the criteria was 
then saved and analysed to ensure the article met the inclusion criteria. The reference 
lists of articles included for review were also examined for relevant articles. These 
were assessed using the same eligibility criteria.   
Data Extraction 
Of the studies that met the inclusion criteria, the following information was extracted 
into a summary table; animal species utilised, animal age, sample size, duration of the 
experiment, the control and intervention diet/s, quinoa content in the intervention 
diet/s, main findings and the quality of the article. The sample size reported in the 
summary table was restricted to animals that were fed either the control or 
intervention diet/s and was not necessarily equal to the sample size for the overall 
experiment. Studies that presented significant findings in graphs without an explicit 
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presentation of the effect size in a table (or in text) had their result summarised in the 
summary table as being significantly different to their respective control.  
Methodological quality assessment 
The methodological design and validity of included studies were assessed by using a 
modified version of the Quality Index (QI), developed by Downs and Black [16] and 
adjusted for use among animal studies by Ainge et al. [17]. This modified tool, known 
as the Methodological Quality Assessment (MQA), was refined further for this 
systematic review to include all animal studies, rather than just studies utilising rats 
(Fig. 1). The MQA provides a quantitative measure of study quality, enabling an 
assessment of the rigour of individual studies to be made. 
Of the 19 review questions, 12 assess the reporting quality, six the internal validity 
and one the power of the studies. A ‘yes’ or ‘no’ response was reported as a one or 
zero for each question respectively, with the total score determined by summing 





1. Were the hypothesis/aims/objectives of the study clearly described within the introduction? 
2. Were the main outcomes to be measured clearly described in the introduction or methods section? 
 
Animal characteristics 
3. Was animal species/strain identified? 
4. Was the animal age at commencement of the study or at conception specified? 
5. Have the animal weights at commencement or at conception of the study been specified? 
6. Have the animal starting numbers, including litter number and sizes been specified? 
7. Have the housing details been specified? 
 
Design and outcomes 
8. Were the interventions of interest clearly described? 
9. Were the main findings of the study clearly described? 
10. Were estimates of the random variability in the data for the main outcomes provided? 
11. Have all important adverse events that may be consequences of the intervention been reported? 




13. Was an attempt made to blind those measuring the main outcomes of the intervention? 
14. Were the statistical tests used to assess the main outcomes appropriate? 
15. Were the main outcomes measures used accurate (valid and reliable)? 
 
Confounding 
16. Was it stated in the text that the animals were randomised to intervention groups? 
17. Was there adequate adjustment for confounding in the analyses from which the main findings were drawn? 
18. Were loses of animals explained? 
 
Power 
19. Was the paper of sufficient power to detect a clinical important effect where the probability value for a difference being due to chance is less than 5%? 
 
Fig. 1 Methodological Quality Assessment questions [17], modified from Downs and Black [16] Quality Index 
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possible ways for a study to fulfil the criteria regarding power. Either an explicit power calculation was provided within the paper, or the study 
identified a significant effect of the treatment with respect to the primary outcome. Reporting and internal validity scores were determined 
separately and reported [17]. In a similar manner to previous work [18], individual study quality was categorised into four discrete quality levels 
based on the overall score: excellent (17-19), good (14-16), fair (10-13) and poor (less than 10). Furthermore, responses to individual quality 
questions across the included studies were summed in order to show general strengths and weaknesses across the literature.  
Results 
The systematic search of the scientific databases resulted in the identification of 888 articles for analysis. After eliminating articles that did not 
fit the eligibility criteria, a total of 17 articles were included in the final review. Hand searching of the reference lists of the included articles 
yielded an additional 2 articles (Fig. 2.) After the application of the eligibility criteria, one of these articles was appropriate to include in the 
review. Therefore the combination of electronic and hand searching resulted in 18 articles being included for review. 
The results from the MQA as well as the quality of the included studies were summarised in descending order (Table 1). The overall scores 
ranged from 6 (poor) [9] to 14 (good) [19,20], with the average total score being 10.9 (fair). The vast majority of studies (12) were classified as 
fair quality. Four were classified as being of poor quality, two as good and none as excellent quality. A summary of the reporting and internal 
validity scores for each study is also provided in Table 1. Generally, the scores achieved in the reporting component of the MQA were superior 
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Table 1 A summary of the reporting, internal validity, total Methodological Quality 
Assessment scores and study quality (excellent, good, fair or poor) attained by each 















[20] Good 9 75 5 71 14 
[19] Good 11 92 3 43 14 
[21] Fair 9 75 4 57 13 
[22] Fair 10 83 3 43 13 
[23] Fair 9 75 3 43 12 
[24] Fair 9 75 3 43 12 
[11] Fair 8 67 3 43 11 
[25] Fair 8 67 3 43 11 
[26] Fair 8 67 3 43 11 
[27] Fair 8 67 3 43 11 
[28] Fair 9 75 2 29 11 
[29] Fair 9 75 1 14 10 
[30] Fair 7 58 3 43 10 
[31] Fair 8 67 2 29 10 
[10] Poor 7 58 2 29 9 
[32] Poor 7 58 2 29 9 
[33]  Poor 8 67 1 14 9 
[9] Poor 5 42 1 14 6 
Average Fair 8.3 69 2.6 37 10.9 
 
Physiological outcomes that were comparatively assessed between animals consuming 
quinoa and a control diet included weight gain and metabolic outcomes (16 studies), 
lipid profiles (6 studies) and antioxidant effects (2 studies). Several studies examined a 
combination of these outcomes, thus explaining the discrepancy between the number of 
studies included in the review (18) and the number of studies showing physiological 
outcomes (24).  
Of the studies pertaining to weight gain, two were of good quality, ten of fair and four of 
poor quality. The vast majority of studies showed a positive association between quinoa 
consumption and decreased weight gain among animals. The largest effect was a 
comparative decrease of 89% between the control and quinoa group [32]. The studies 
that showed a comparative increase (of up to 10%) in weight gain among animals fed 
quinoa were unable to show statistically significant increases. A general trend among the 
studies investigating weight gain was for relative differences in weight gain between the 
quinoa and control group to narrow as study quality declined. Three studies investigating 
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 (Indication of Bias, Confounding & Power) 
Item 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 
Positive Response 14 15 17 10 10 15 17 15 17 18 0 1 0 15 15 5 0 3 9 
Proportion of Positive 
Responses (%) 
78 83 94 56 56 83 94 83 94 100 0 6 0 83 83 28 0 17 50 
a Methodological Quality Assessment 
 




































Weight gain Control group gain – 1323g. Weight 
gain (with increasing raw quinoa 
content) 1247g (p>0.05), 1065g 
(p<0.05) and 765g (p<0.05). Weight 
gain (with increasing processed quinoa 
content) 1232g (p>0.05), 1079g 
(p>0.05) and 875g (p<0.05). 
Good 





with raw or 
processed 
quinoa 
50, 150 Control group gain after 20 days – 
627g. Weight gain (group eating 
150g/kg processed quinoa) 593g 
(p<0.05) after 20 days. Weight gain did 





28 days 400 28 days Basal 
diet 
without 





Weight gain Control group gain – 294g/day. Quinoa 
groups gained 280-307g/day (p=0.41).  
Jejunum epithelial conductance of 
Good 
 
1 The quality of the studies (excellent, good, fair or poor) was based on the Methodological Quality Assessment score: excellent (17-19), good (14-16), fair (10-13) and poor 







control group – 22mS/cm2. In quinoa 
groups, conductance was 24-25mS/cm2 
(p=0.04). 














Sedentary control group gain – 60.2g, 
exercised control group gain – 94.2g. 
Weight gain, (among quinoa fed 
groups) sedentary – 16.5g (p<0.05) and 
exercised – 60.0g (p<0.05)  
 
Sedentary control group triglycerides – 
92.9mg/dL, exercised control group – 
63.1mg/dL. Triglycerides (among 
quinoa fed groups) sedentary – 
73.9mg/dL (p<0.05) and exercised – 
60.9mg/dL (p>0.05). 
Non-significant difference in 






























LF group gain – 3.0g. HF group and 
HFQ group gain 5.1g (p<0.001) and 
5.6g (p<0.001) respectively.  
HF group epididymal adipose tissue 
(EAT) – 28.8mg/g body weight. HFQ 
EAT – 21.7mg/g body weight 
(p<0.01).  
HF group plasma leptin – 6.0ng/ml. 
HFQ group plasma leptin – 3.9ng/ml 
(p<0.05).  
Plasma adiponectin and expression of 
mRNA for SREBP-1c2 and PAI-1 were 
lower in HFQ compared to LF group 
Fair 
 












Expression of mRNA for LPL3, PPAR-
γ, PEPCK, Leptin, TLR4, MCP1, 
CD68, GILZ, OST and PAI-1 were 
lower in the HFQ group and mRNA 
expression for UCP24 and UCP3 were 
higher in HFQ group compared to the 
HF group (all p<0.05). 
 
LF and HF group triglycerides – 
0.50g/l and 0.53g/l. HFQ group 
triglycerides – 0.51g/l (p>0.05).  
LF and HF group plasma cholesterol – 
1.25g/l and 1.33g/l. HFQ group plasma 














The quinoa group had lower liver 
GPX5 and CAT, lower CAT in the 
testis and higher GPX in the spleen (all 
p<0.05) compared to the corn control.  
The quinoa with fructose group showed 
lower MDA6 levels compared to the 













310 Lipids Cholesterol, triglycerides and LDL of 
the quinoa group were significantly 
lower (p<0.05, p<0.05, p<0.008 
respectively) than levels in the corn 
control group. 
Fair 
[11] Male Not 15 4 weeks Casein 1. Quinoa 680 Weight gain Control group gain – 57g. Weight gain Fair 
 
3 LPL = Lipoprotein Lipase, PPAR-γ = Peroxisome Proliferator-Activated Receptor-γ, PEPCK = Phosphoenolpyruvate Carboxykinase, TLR4 = Toll-Like Receptor 4, MCP-1 
= Monocyte Chemoattractant Protein-1, CD68 = Cluster of Differentiation 68, GILZ = Glucocorticoid-induced Leucine Zipper, OST = Osteopontin 
4 UCP2 = Uncoupling Protein 2, UCP3 = Uncoupling Protein 3 
5 GPX = Glutathione peroxidase, CAT = Catalase 





stated  flour 
2. Cooked 
quinoa 
for the quinoa flour group – 43g 
(p>0.05) and for cooked quinoa group 
– 89g (p<0.01).  
Control group protein efficiency ratio 
(PER) – 2.67. PER for quinoa flour 
group – 2.09 (p<0.01) and 2.71 












953.5 Weight gain After 14 days, control group gain – 
76g. Weight gain in raw and polished 
quinoa group 64.2g and 67.6g 
respectively (both p<0.05).  
Fair 








835 After 21 days, control group gain – 
486.9g. Weight gain in raw and 
polished quinoa group 118.6g and 
210.1g respectively (both p<0.05). 








962.5 After 7 days, control group gain – 
87.5g. Weight gain in raw, polished 
and washed quinoa group 53.0g 
(p<0.05), 54.9g (p<0.05) and 92.9g 
(p>0.05) respectively. 








800 After 31 days, control group gain – 
891.4g. Weight gain in raw, polished 
and washed quinoa group 160.4g, 
















Control group gain – 14.5g. Quinoa 
group gain – 15.1g (p>0.05).  
 
Control and quinoa group serum α-
Tocopherol – 8.5μg/ml and 5.6μg/ml  
(p<0.05) respectively. Control group 
serum and liver MDA 2.0nmol/mL and 
33.3nmol/g respectively. Quinoa group 
serum and liver MDA 3.0nmol/mL and 
40.3nmol/g (both p<0.05) respectively. 
Fair 
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No differences in serum or liver GPX 
(p>0.05).  
[27] Male Crj: 
CD-1 
(ICR) mice 














Control group gain – 11.28g. Weight 
gain (with increasing quinoa extract) 
12.02g and 10.78g (p>0.05).  
 
Plasma cholesterol (0 to 5% quinoa) 
268.2mg/dl, 199.9mg/dl (p<0.05), 
204.5mg/dl (p<0.05). Liver cholesterol 
(0 to 5%) quinoa 10.31mg/dl, 
8.16mg/dl (p>0.05), 6.30mg/dl 
(p<0.05).  
Plasma triglycerides (0 to 5% quinoa) 
84.5mg/dl, 55.4mg/dl, 45.2mg/dl 
(p>0.05).  Liver triglycerides (0 to 5% 
quinoa) 14.06mg/g, 10.36mg/g, 
9.24mg/g (p>0.05).  
Daily faecal bile acid (0 to 5% quinoa) 
125.8, 212.3 (p<0.05), 202.5μg/50g 
body weight (p<0.05).  
Expression of HMG-CoA7 reductase 
was significantly lower (p<0.05) in the 









16 15 days Casein Quinoa in 
place of casein 








No difference in weight gain between 
control and quinoa group (p>0.05). 
Control group and quinoa group 
postprandial CCK8 levels 8.63ng/ml 
and 12.56ng/ml (p<0.01) respectively. 
No differences in fasting CCK, ghrelin 
and leptin and postprandial ghrelin and 
leptin between groups (p>0.05). 
Fair 
 
7 HMG-CoA reductase = 3-hydroxy-3-methylglutaryl coenzyme A 





Cholesterol in the quinoa group was 
significantly lower (p<0.01) than the 
control group. 
[29] Wistar rats Not 
stated 










Weight gain The control group gained more weight 
than the bitter, washed bitter and sweet 
quinoa groups (no statistics provided). 
Fair 











50, 100 Weight gain Control group gain – 294g/day. Weight 
gain (with increasing quinoa content), 





6 weeks Not 
stated 













Over a 24-hour period, the respiratory 
quotient and glucose oxidation of the 
HFQ group was higher than the control 
group (both p<0.05). Control and HFQ 
plasma leptin – 4.2ng/ml and 3.6ng/ml 
(p>0.05) respectively.  
 
Control and HFQ plasma triglycerides 
– 0.62g/L and 0.68g/L (p>0.05) 
respectively. Over a 24-hour period, 
HFQ faecal lipid content was higher 
than control group (p<0.05).  
Fair 
[10] Rats Not 
stated 






641 Weight gain Control and quinoa group gain – 130g 
and 126g (p>0.05) respectively. 
Control and quinoa group protein 






32 days 8 10 days Basal 
diet with 
casein 
Basal diet with 
quinoa 
758 Weight gain Control and quinoa group gain – 
11.0g/day and 1.2g/day respectively 












Weight gain The quality of protein from quinoa was 
























Weight gain Gain (in increasing order) was control 
group, washed quinoa group and raw 
quinoa group (no statistics provided). 
Poor 
 
weight gain also analysed the concentration of hormones involved in the regulation of appetite. The consumption of quinoa in the diet was 
associated with a decrease in the concentration of plasma leptin by between 14% and 35% [31,22]. Post-prandial ghrelin and cholecystokinin 
differences among the quinoa group were respectively 5.4% lower and 45.5% higher than levels among the control group [28]. In addition, one 
of these studies investigated differences in the release of cytokines  (such as monocyte chemoattractant protein-1, interleukin-1β and 
plasminogen activator inhibitor-1) from adipose tissue (adipokines) among mice fed high fat diets [22]. The addition of quinoa to the diet 
decreased the mass of adipose tissue and significantly reduced the expression of inflammatory adipokines [22]. 
Six studies, all of fair quality, investigated the impact of quinoa consumption on lipids. Across the body of literature, the consumption of quinoa 
was associated with decreases in cholesterol, triglycerides, low-density lipoprotein (LDL) and high-density lipoprotein (HDL). The largest 
decreases in cholesterol, triglycerides and HDL were 25.5%, 46.5% and 9.6% respectively [27]. It was not possible to accurately quantify the 
relative decreases in LDL levels because none of the studies reported the level of this biomarker in a tabular format. It did however appear that 
as the concentration of quinoa in the diet rose above50g/kg so too did the efficacy of reductions in cholesterol, HDL and LDL. This apparent
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relationship between dose and effect did not appear to persist for decreases in 
triglyceride levels. 
Finally, the two studies investigating the antioxidant effects of quinoa were both of fair 
quality. These studies measured the concentration of antioxidant compounds such as 
glutathione peroxidase, catalase and superoxide dismutase as well as markers of 
oxidative damage such as malondialdehyde. The expression of these antioxidant 
compounds showed a vast degree of variability between organs and between animals 
subjected to varying degrees of oxidative stress. Measures of lipid peroxidation between 
the two studies were in complete contrast. The inclusion of quinoa in the diet resulted in 
a decrease in lipid peroxidation by between 29.6% and 66.1% [23] but also a 21% to 
50% increase in peroxidation compared to the control group [26]. 
Discussion 
Among the included animal model studies, weight gain, lipid profiles and antioxidant 
responses were the main physiological outcomes affected by quinoa consumption. 
However, the body of literature supporting these effects showed wide variation in terms 
of rigour and quality. The value of conducting a defined quality assessment for 
evidence-based review was demonstrated here. Specifically, the MQA tool showed that 
the quality of animal studies could be improved by incorporating design aspects such as 
blinding, randomisation and power calculations. These methodological tools would help 
minimise the impact of bias, including improved reporting on study design and 
corresponding MQA score.  
Effects on Weight Gain 
Animal feeding experiments investigating quinoa as a potential food source have 
identified the presence of saponins, which have been implicated in the reduction of 
weight gain and feed consumption among animals [25]. There is however potential for 
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saponins to play a role in human nutrition, particularly in developed countries, where 
over nutrition is more widespread than under nutrition. 
Across the body of literature, it appeared that the presence of saponins in quinoa was 
connected to decreased weight gain. This association was replicated in rats, mice and 
chickens and was achieved using a range of different dietary concentrations of quinoa. It 
was however not replicated in two piglet studies [19,30], with speculation that the 
concentration of saponins in the diet was too low to induce a significant change in 
weight gain. More generally, it became apparent that as the methodological quality of 
the studies decreased, so too did the detection of differences in weight gain between 
treatment and control groups.  
Despite the underlying weight loss effect, the magnitude of the effect varied across 
studies, possibly due to the different concentration of saponins present in quinoa seeds. 
Each variety of quinoa has a slightly different composition of saponins and each study 
used processing techniques to prepare the intervention diet, which may have resulted in 
the loss of saponin fractions. Evidence of these contrasting effects was seen in the two 
good quality studies where saponins appeared to inhibit weight gain among chickens 
[20] but had no effect among piglets [19]. Both studies used large sample sizes, 
randomisation and employed a similar time period for the intervention to be performed. 
The saponin content was however markedly lower in the latter study with piglets.  
It was postulated that the mechanism through which saponins operate revolves around 
their ability to interfere with intestinal function [29]. Studies in an Ussing chamber 
showed that the presence of saponins derived from quinoa resulted in an increased 
conductance of pig jejunum [19]. This finding suggests that there was an increase in the 
permeability of the intestinal lining, resulting in a decreased capacity to actively absorb 
nutrients for animal growth and development.  
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The bitter taste of saponins has been implicated in reducing the palatability of certain 
quinoa varieties. This was shown to decrease food intake [20,21,28,29] and was given as 
an additional explanation for the incidence of decreased weight gain. A further rationale 
for the decreased food intake may be due to changes in the expression of gut hormones 
upon the consumption of quinoa. In particular, post-prandial cholecystokinin levels were 
elevated after the consumption of quinoa [28], resulting in a feeling of satiety. Although 
most commercially available quinoa has been processed to remove the bitter tasting 
saponins, the presence of protein, dietary fibre and phenolics within the seed may be 
capable of inducing feelings of satiety, assisting in the reduction of food intake and 
weight gain. 
The ability of quinoa to induce decreased weight gain was unable to be replicated among 
mice fed a high fat diet with added quinoa [22]. Despite the null finding, the mice fed 
quinoa showed a slight decrease in adipose tissue mass as well as a decrease in the 
expression of lipid storage genes such as lipoprotein lipase and peroxisome proliferator-
activated receptor-γ [22]. The quinoa extract used in this study was rich in the naturally 
occurring steroid hormone, 20-hydroxyecdysone. This compound is structurally similar 
to Vitamin D, which has been shown to affect lipid accumulation in adipose tissue [22]. 
It was postulated that Vitamin D receptors formed suitable binding sites for 20-
hydroxyecdysone, enabling it to influence the expression of genes responsible for lipid 
storage, however this mechanism requires further elucidation.   
A recent follow up study suggested that the presence of 20-hydroxyecdysone in quinoa 
was responsible for an increase in glucose oxidation and respiratory quotient (RQ) 
among mice [31]. However, the explanation for the change in the RQ appears to be 
counterintuitive. It was suggested that this was indicative of a decrease in fat oxidation 
and decreased rate of de novo lipogenesis [31]. These both seem unlikely since levels of 
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lipid oxidation among the quinoa and the control diet did not differ [31] and 
furthermore, increased, rather than decreased de novo lipogensis from carbohydrate 
would lead to an increase in the RQ value [34].  
A high fat diet fed to mice was shown to increase the expression of inflammatory 
cytokines released from adipose tissue [22]. This agrees with findings among 
overweight and obese individuals that display elevated levels of inflammation due to the 
release of cytokines from adipose tissue [35]. The addition of a quinoa extract rich in 20-
hydroxyecdysone to the high fat diet reversed the expression of inflammatory cytokines 
to levels associated with a low fat diet. This effect may be due to a decrease in adipose 
tissue mass among the quinoa group and therefore less capacity to release adipokines. It 
may also be due to the action of 20-hydroxyecdysone and its metabolites binding 
membrane receptors and as such influencing signal transduction and the expression of 
adipokines. Future research should aim to identify the underlying cause, which is likely 
to involve a complex interplay between these factors.  
The concentration of quinoa needed to induce weight loss effects in a human cohort 
must be explored in order to determine if the amount needed to achieve these effects is 
attainable in the context of a regular diet. In addition, further studies investigating the 
action of quinoa on weight gain should control the energy density by using isoenergetic 
diets or calculate average energy intake by measuring the quantity of food consumed in 
order to ascertain the effect of quinoa on weight gain independent of energy intake. 
Identifying the potential for quinoa to influence weight gain is of such interest due to the 
unacceptably high incidence of overweight and obesity; estimated to be 39% and 13% of 
the global population respectively [36]. This represents a significant public health 
burden, particularly since overweight and obesity are known risk factors for a chronic 
diseases such as cardiovascular disease, Type 2 diabetes and some cancers [36].  
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Effects on Lipid Profile 
The studies investigating lipids were all of fair quality, and showed similarities in terms 
of their weaknesses. Baseline measures were not explicitly reported, which is a basic 
limitation of the findings. It could be argued that baseline measures among the animals 
would not show significant variability due to the similarity in the ages and species of 
animals. However, providing baseline measures would enable a comparison of changes 
in lipid biomarkers between intervention and treatment diets to be performed. This 
would be more informative than a comparison of levels at the completion of the study.  
Despite this limitation, it was shown that the inclusion of quinoa in the diet had a 
significant effect on cholesterol levels in as little as 15 days [28]. A similar acute 
cholesterol lowering effect has been previously reported among humans consuming β-
glucan, where favourable outcomes were noted in as little as two weeks [37]. It was 
proposed that proteins present within the quinoa seed facilitated a reduction in the re-
absorption of bile acids and a reduction in hepatic cholesterol synthesis. This was 
supported by findings that bile acid excretion was elevated and the expression of hepatic 
HMG-CoA reductase was decreased among mice fed a quinoa diet [27]. This is a similar 
mechanism to that indicated in other food components such as β-glucans [38], which are 
effective at decreasing cholesterol [37].  
The presence of 20-hydroxyecdysone in the outer casing of the quinoa seed has also 
shown potential lipid lowering properties. In particular, it was implicated in causing 
modifications to lipid absorption, which caused significantly higher levels of lipids to be 
excreted in the faeces of mice fed a high fat diet supplemented with quinoa [31]. 
Additionally, the cholesterol lowering properties of quinoa were sustained when 
hypercholesterolemia [27] and oxidative stress [24] were induced through the addition of 
cholesterol and fructose to the diet respectively. Collectively, this suggests that quinoa 
may play an active role in the metabolism of cholesterol.  
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Based on the literature, it appears that the cholesterol lowering properties of quinoa only 
become significant when at least 2.5% of the diet (2.5 grams per 100 grams) contains 
quinoa [27]. In contrast, there is very little evidence to suggest that the concentration of 
quinoa has an obvious impact on triglyceride levels. It appears that significant changes 
in triglycerides are not observed until quinoa is consumed in the diet for at least 30 days 
[21]. A greater understanding of the process occurring is therefore necessary before firm 
conclusions can be drawn regarding quinoa and the impact on triglycerides.     
None of the included studies were able to demonstrate that quinoa had a significant 
impact on HDL, while only one study showed that a diet containing quinoa was able to 
significantly lower LDL levels [24]. Interestingly, this study also had the highest dose of 
quinoa and was performed over the longest time period. The tentative conclusions of 
these findings are that consuming quinoa can reduce LDL over a longer time frame. 
Extending the intervention period (beyond four or five weeks) may therefore lead to 
additional improvements in the lipid profile. However, without the guidance of previous 
work investigating quinoa consumption over a longer duration, it is difficult to 
determine the optimum intervention period.  
Heterogeneity in study design is likely to have played a part in generating the variable 
outcomes. This heterogeneity included differences in animal species, animal ages, 
quinoa content in the diet and duration of the intervention period. In addition, it was not 
clear which bioactive compound/s were responsible for the underlying effects observed 
in these studies. Animal studies should further investigate the lipid lowering effects 
imparted by quinoa and attempt to refine the possible mechanisms that are in operation. 
It is well established that high cholesterol levels are a risk factor for developing 
cardiovascular disease [37]. Therefore, food products that can assist in improving the 
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lipid profile in the human body, without radically altering the diet are extremely 
desirable from a functional and nutritional perspective.  
Antioxidant Effects 
The antioxidant activity of quinoa has been previously investigated using validated 
methods such as the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay and Ferric reducing 
antioxidant power (FRAP) assay [39]. This review identified two animal studies that 
explored the physiological effect of quinoa consumption on markers of oxidative stress 
and concentration of antioxidant compounds.  
The antioxidant properties of quinoa were most prominent during periods of oxidative 
stress. Plasma lipid peroxidation was decreased while the expression of antioxidant 
compounds such as glutathione peroxidase and catalase were elevated in several organs 
[23]. This suggests that quinoa has the ability to regenerate antioxidant species that can 
then attack free radicals and therefore protect tissues against oxidative damage. 
However, these antioxidant properties were less clear when oxidative stress was not 
intentionally induced in the diet. Since similar analytical methods were used to 
determine lipid peroxidation, differences in study design are more likely to explain the 
contrasting results. This includes the use of quinoa extracts that did not possess 
antioxidant properties, short intervention periods and the use of vitamin supplements in 
the control diet, which may have acted as antioxidants and nullified any advantageous 
effects that were generated by consuming quinoa [26].   
A limitation of both studies investigating the antioxidant potential of quinoa was the 
absence of a detailed analysis (identification and quantification) of the main (bioactive) 
compounds. Quinoa is known to possess compounds with strong antioxidant activity, 
such as flavonoids and phenolic acids [39], however the presence of these compounds 
was not assessed in either study despite the phytochemical composition of quinoa known 
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to vary due to genetic and environmental factors. Additionally, there was no attempt to 
determine the presence of potential in vivo metabolites in the blood, urine or faeces of 
animals, which is crucial in understanding the in vivo bioactivity of compounds found in 
plant foods such as quinoa. As a first step, future studies should determine the presence 
of bioactive compounds followed by an assessment of the bioactivity of these 
compounds. 
It is well established that the consumption of foods rich in phytochemicals is associated 
with a decrease in oxidative stress [40] and risk of mortality from cardiovascular disease 
[41]. However, it is necessary to identify the specific phytochemicals present in the 
quinoa seed and their relative bioactivity in order to begin to understand the potential 
physiological benefits that they could impart upon consumption. This will provide a 
more thorough understanding of their action and could be used to design experiments 
that test their efficacy in a human population. 
Limitations of Review 
Throughout the design and completion of this literature review, steps were taken to 
minimise the level of bias in the generation of the results. Despite these efforts, there are 
several limitations that have been identified. Firstly, studies were included regardless of 
their overall quality and as such, possible associations between dietary consumption and 
physiological effects may have been under or overestimated. This was mitigated to a 
certain degree by using a quality-rating tool, which provided a transparent guide to 
ranking studies within the body of literature.  
The second limitation refers to the doses consumed by animals in the respective studies. 
It is difficult to infer the dose that would be appropriate in a human context and whether 
dose dependency would persist, however, this is the critical issue and needs to be 
addressed in any future human study. Additionally, this review treats studies that use 
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isolated extracts, processed forms and raw forms of the quinoa seed as equally valid 
dietary interventions. The weakness of this assumption is that humans eat foods and not 
food extracts. Therefore it is difficult to predict the efficacy with which specific 
compounds present in the quinoa seed would impact human health when consumed as 
part of the diet. This is a limitation inherent in research exploring the effect of specific 
compounds or nutrients. The underlying aim of this review however, was to identify 
potential physiological effects of quinoa. Exploring the efficacy of quinoa in the whole 
diet would be an appropriate procedure once these initial outcomes are identified.  
Recommendations for Future Research 
Animal studies provide a valuable tool for exploring the possible mechanisms that food 
components operate through in delivering a health outcome. These types of studies 
cannot be used to validate health claims within the regulatory context, but they can be 
used to inform the design of future human clinical studies. Despite the heterogeneity 
introduced through the use of differing animal models, doses of quinoa, sample sizes and 
study time frames, it appears that the consumption of quinoa generates beneficial 
physiological outcomes among animals.  
The process of rating the quality of the individual studies is a prudent technique to 
identify the underlying rigour with which the physiological effects were achieved. In 
particular, there appeared to be a lack of blinding and randomisation in the majority of 
studies, which should be addressed in future work. In addition the reliability of future 
work could be improved by using larger samples, while the scope could be improved by 
varying the dose of quinoa used in order to elucidate possible dose-dependent effects. 
Based on the findings from this systematic review, human studies that investigate the 
impact of quinoa with varying levels of saponins on weight gain would be a viable 
experiment to perform. In addition, human studies could investigate the impact of 
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quinoa consumption on the lipid profile. Despite the potential antioxidant properties 
shown by quinoa, systematic analytical research using state of the art analytical 
equipment such as HPLC-ESI-MS and NMR spectroscopy is required to identify and 
quantify the main bioactive compounds in quinoa before human studies can be justified. 
Conclusion 
This systematic review of the animal model literature has identified that the 
consumption of quinoa may lead to comparatively lower weight gain, an improved lipid 
profile and potential antioxidant effects. These physiological outcomes require further 
investigation, with a particular focus on elucidating the mechanism through which 
bioactive compounds, such as saponins, quinoa proteins, polyphenolic compounds and 
20-hydroxyecdysone operate to deliver these desirable outcomes.  
Despite the limitations of the animal studies that have been performed to date, there is 
burgeoning interest in quinoa as a food source and a steady uptake of it in the diet. To 
add further substance to the health properties that quinoa is perceived to possess, 
rigorously controlled human studies that aim to investigate the three key outcomes 
identified in this review should be performed. The identification of health benefits in a 
human population would encourage further investment in quinoa and galvanise public 
perception that it is a desirable food that could be consumed as part of a balanced diet. 
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